In-Silico and In-Vitro Assessment of Selected Fatty Acids against Vibrio Spp..
DOI:
https://doi.org/10.31436/imjm.v25i02.3014Keywords:
Vibriosis, Vibrio parahaemolyticus, Vibrio alginolyticus, Oleic acid, Lauric acidAbstract
INTRODUCTION: Vibrio spp. is a zoonotic pathogen that can cause mild or fatal infection in human and animals. The overuse of antibiotics has led to increasing antimicrobial resistance (AMR). Fatty acids (FAs) offer a potential alternative due to their broad-spectrum antibacterial activity. Hence, this study aimed to investigate the anti-Vibrio effects of oleic acid (OA), lauric acid (LA), palmitic acid (PA), and stearic acid (SA) through in-vitro and in-silico approaches. MATERIALS AND METHODS: Molecular docking was performed using PyRx against 21 receptors belonging to Vibrio spp. retrieved from the Protein Data Bank (PDB) for in-silico investigation. To validate the findings, LA, OA, PA and SA were experimentally tested. Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) assays were conducted in-vitro against Vibrio alginolyticus and Vibrio parahaemolyticus. RESULTS: Molecular docking results revealed that OA exhibited the lowest binding energy (min=-7.2, mean=-4.8). OA also showed the second-highest number of hydrogen bond interactions and ranked third in van der Waals interactions. FAs demonstrated significantly stronger affinity (p<0.05) to proteins related to toxin production, nutrient acquisition, and quorum sensing. In-vitro assays aligned with in-silico where OA had the lowest MIC (125 µg/mL) against both V. alginolyticus and V. parahaemolyticus and exhibited bactericidal activity against V. alginolyticus at 500 µg/mL. CONCLUSION: Therefore, OA is a promising anti-Vibrio agent that might regulate environmental sensing and interaction with small molecules. The receptors 3MRU, 3WPW, 3A57 and 3X0T, matched in-vitro results and could be used in the design of new treatments for vibriosis.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
All material submitted for publication is assumed to be submitted exclusively to the IIUM Medical Journal Malaysia (IMJM) unless the contrary is stated. Manuscript decisions are based on a double-blinded peer review process. The Editor retains the right to determine the style and if necessary, edit and shorten any material accepted for publication.
IMJM retain copyright to all the articles published in the journal. All final ‘proof’ submissions must be accompanied by a completed Copyright Assignment Form, duly signed by all authors. The author(s) or copyright owner(s) irrevocably grant(s) to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate the research article in its entirety or in part, in any format or medium, provided that no substantive errors are introduced in the process, proper attribution of authorship and correct citation details are given, and that the bibliographic details are not changed. If the article is reproduced or disseminated in part, this must be clearly and unequivocally indicated.
